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Invited Comment on: “Beneﬁt of Revascularization to Critical Limb Ischemia
Patients Evaluated by a Patient-oriented Scoring System”
F. Bastos Gonçalves*, H.J.M. Verhagen
Erasmus University Medical Center, Vascular Surgery, ’s-Gravendijkwal 230, 3015 CE Rotterdam, NetherlandsThe authors present functional outcomes after critical limb
ischaemia (CLI), and propose a score to predict the beneﬁt of
revascularisation. This perspective very well complements the
traditional patency and limb-salvage outcomes, which probably
interest doctors more than patients. The authors found endovas-
cular (and hybrid) procedures to have a signiﬁcant positive impact
on postoperative functional status. This adds to the still-spurring
discussion over the optimal revascularisation strategy for CLI,
fuelled by the recent Bypass versus Angioplasty in Severe Ischaemia
of the Leg (BASIL) trial long-term results.1
The main limitation of this study is the lack of a control group.
Alternatives to revascularisation (palliation or amputation) seem
counter-nature for the vascular surgeon, but may be more helpful
and/or realistic for patients in whom heroic limb salvage will most
likely fail. Even when revascularisation is possible, some patients
simply beneﬁt more with a primary amputation, often ending
a long cycle of pain, infection and risk to life, and perhaps
promoting a faster recovery to an improved functional status.2
When exclusively looking at patients undergoing revascularisa-
tion, no comparison is possible with functional status following
amputation/palliation. Therefore, any recommendation concerning
management simply cannot be made due to the absence of
a comparison.
Roughly 10e50% of all CLI patients (depending on geography)
are considered poor candidates for revascularisation. When more
than 95% of patients are revascularised, bias is certainly present and
may explain some relatively poor results (such as pain relief and
wound healing of 18.5% and 14.5%, at 1 year, respectively) andDOI of original article: 10.1016/j.ejvs.2012.01.025.
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poor runoff vessels were signiﬁcant predictors for unchanged or
worsened functional status after multivariate analysis.
Lastly, the presented sample may not represent the typical CLI
population, since patients with acute limb ischaemia were also
included, and these frequently bear a different aetiology, require
distinctive intervention strategies and have dissimilar prognosis.
The authors used the Rutherford classiﬁcation to deﬁne CLI, which
does not account for chronicity, as recommended by the Inter-
Society Consensus for the Management of Peripheral Arterial
Disease (TASC II).3
In conclusion, this publication provides interesting insight on
the functional status of patients with severe arterial disease, up to 1
year after revascularisation. However, a critical view on the
methods used is mandatory to adequately interpret the presented
results. Further research with a higher level of evidence is required
before a change in practice may be considered.References
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